#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metachromatic leukodystrophy Craniopharyngioma Soft tissue necrosis Niemann-Pick disease Marginal zone lymphoma Porphyria non-acute Soft tissue sarcoma Dedifferentiated liposarcoma Neonatal asphyxia Encephalopathy neonatal Atypical haemolytic uraemic syndrome Langerhans cell sarcoma Haemophilia Leiomyosarcoma metastatic Paget's disease of the vulva More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Life with Disease Lennox-Gastaut syndrome – Trials in Disease Antisynthetase syndrome – Diagnostics Antithrombin III deficiency – Life with Disease Uterine leiomyosarcoma Systemic sclerosis pulmonary – Basic Information VEXAS syndrome Burkitt’s lymphoma – Life with Disease Alexander disease – Basic Information Chondrosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986449-03 Apremilast PRT3789 Ferumoxytol Arginine Hydrochloride Albiglutide Bilastine RUBIDIUM CHLORIDE Bexmarilimab Rbd5044 Sodium Ganaxolone PRILOCAINE HYDROCHLORIDE Atl001 Cefotaxime Leuprorelin Acetate Canakinumab Aclidinium Bromide ZINC GLUCONATE Piperacillin Sodium Aavanc80-5'Hotof More therapies…

    Learn about Your Condition

    Colon cancer stage III Lipid metabolism disorder Fragile X syndrome Paraganglion neoplasm Hairy cell leukaemia recurrent Plasma cell myeloma recurrent Ewing's sarcoma metastatic Transplantation complication Langerhans' cell histiocytosis Friedreich's ataxia Hepatic cirrhosis Nephrolithiasis Acute cardiac event Circulatory collapse Papulopustular rosacea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Progressive multiple sclerosis

  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Finland

  • Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Nervous system disorder
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Kyv-101
    • Ublituximab
    • Ocrelizumab
    Austria Belgium Germany Italy

  • Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Ocrelizumab
    • Methylprednisolone
    Czechia Denmark France Germany Italy The Netherlands +1

  • Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    • Nervous system disorder
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Interferon Beta-1A
    • Natalizumab
    • Ozanimod
    Belgium
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!